Pancreatic Cancer

  • RTOG 0848 (SOMC Pending)- Phase III Trial Evaluating both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma (Temporary Closure)
  • SWOG S1115- Phase II Randomized Study of Selumetinib and Akt Inhibitor MK2206 Versus mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Previously Treated Patients With Metastatic Pancreatic Cancer
  • ECOG E2211- Phase II Randomized Study of Temozolomide or Temozolomide and Cepecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors (Temporary Closure)